This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
iot: Archive
Can Verizon's Empower Field Network Infrastructure Upgrade Aid Shares?
by Zacks Equity Research
VZ's Wi-Fi 6E upgrade at Empower Field boosts fan connectivity with 2,400 new access points and a faster, safer stadium network.
TPositive Net Change VZPositive Net Change TMUSNegative Net Change
internet iot mobile tech-stocks
Should You Buy Southern Missouri Bancorp (SMBC) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
SMBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Verizon or American Tower: Which is the Smarter 5G Bet for 2026?
by Supriyo Bose
VZ's lower valuation and strong 5G momentum give it an edge over AMT in the 2026 telecom race.
AMTNegative Net Change TPositive Net Change VZPositive Net Change TMUSNegative Net Change
communications iot mobile tech-stocks telecom
First Financial Bancorp (FFBC) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
FFBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Arista Scales Up Campus Wireless With VESPA Tech: Stock to Aid?
by Zacks Equity Research
ANET unveils VESPA to boost campus Wi-Fi with seamless roaming, massive scale support, and upgraded AI-driven AVA for smarter network operations.
CSCONegative Net Change ANETNegative Net Change HPENegative Net Change
computers internet internet-content iot tech-stocks
INTC vs. PINS: Which Tech Stock Deserves a Spot in Your Portfolio?
by Supriyo Bose
Intel's AI-driven turnaround and strong funding edge out Pinterest's ad growth, making it the better portfolio pick for now.
AMZNNegative Net Change INTCNegative Net Change AMDNegative Net Change NVDANegative Net Change PINSNegative Net Change
artificial-intelligence computers internet-content iot mobile semiconductor tech-stocks telecom
QCOM vs. ASTS: Which Wireless Innovator is the Smarter Bet for 2026?
by Supriyo Bose
Qualcomm's steady growth and stronger valuation may give it the edge over AST SpaceMobile in the 2026 wireless showdown.
QCOMNegative Net Change TPositive Net Change VZPositive Net Change ASTSNegative Net Change
artificial-intelligence communications iot mobile semiconductor tech-stocks telecom
ANET vs. IBM: Which Hybrid Cloud Stock is the Better Buy for 2026?
by Supriyo Bose
IBM edges out Arista as the better hybrid cloud pick for 2026, thanks to valuation appeal and multi-cloud momentum.
AMZNNegative Net Change MSFTNegative Net Change IBMNegative Net Change ANETNegative Net Change
artificial-intelligence cloud-computing computers iot software tech-stocks
3 Communication Stocks Set to Benefit From Industry Strength
by Supriyo Bose
The infrastructure upgrade for digital transformation, fiber densification and 5G rollout should help the Zacks Communication - Infrastructure industry thrive. COMM, IHS and BAND are likely to benefit from the continued transition to cloud networks.
COMMNegative Net Change IHSNegative Net Change BANDPositive Net Change
cloud-computing communications iot tech-stocks
Should You Buy Alpine Income (PINE) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PINEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
T Boosts Network Readiness for Winter Storms: Can it Drive Growth?
by Zacks Equity Research
AT&T bolsters its network with snow-ready gear, backup power and rapid-response teams to keep customers connected through winter storms.
TPositive Net Change VZPositive Net Change TMUSNegative Net Change
communications iot mobile tech-stocks
CLS Stock Surges 260% in a Year: Can It Sustain This Growth Pace?
by Supriyo Bose
CLS surges 260% in a year, fueled by AI demand, product innovation and a bullish 2025 revenue and earnings outlook.
JBLNegative Net Change FLEXNegative Net Change CLSNegative Net Change
artificial-intelligence electronics iot tech-stocks
The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PNTGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will IBM's Purported Confluent Buyout Spur the Growth Engine?
by Arijit Sarkar
IBM's reported $11 billion move for Confluent aims to strengthen its real-time data capabilities and expand its cloud-native services footprint.
AMZNNegative Net Change MSFTNegative Net Change IBMNegative Net Change CFLTNegative Net Change
cloud-computing computers iot tech-stocks
ASTS Shares Zoom on Upcoming BlueBird 6 Launch: Worth Buying Now?
by Supriyo Bose
ASTS jumps 18.3% ahead of BlueBird 6 launch as investors eye its next-gen satellite and major carrier deals.
TPositive Net Change VZPositive Net Change AVNWNegative Net Change CMTLNegative Net Change ASTSNegative Net Change
communications iot mobile tech-stocks telecom
ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ATNIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TGSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Si-Bone (SIBN) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SIBNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Do Rising Earnings Estimates Strengthen the Case for Qualcomm Stock?
by Supriyo Bose
QCOM's earnings estimates are rising on Snapdragon and auto strength, but China risks and margin pressure loom.
QCOMNegative Net Change AVGONegative Net Change HPENegative Net Change
artificial-intelligence communications iot mobile semiconductor tech-stocks telecom
Are Rising Earnings Estimates a Solid Reason to Bet on ANET Stock?
by Supriyo Bose
Earnings estimates for Arista are climbing on solid cloud demand and software strength, but margin pressure clouds the outlook.
CSCONegative Net Change ANETNegative Net Change HPENegative Net Change
cloud-computing iot software tech-stocks
After Golden Cross, Assured Guaranty (AGO)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AGOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Intel Stock Surges on Apple Deal Buzz: Can INTC Sustain This Momentum?
by Supriyo Bose
INTC jumps 8.7% on buzz of a potential Apple chip deal, but margin pressure and fierce competition loom large.
INTCNegative Net Change AAPLPositive Net Change AMDNegative Net Change NVDANegative Net Change
artificial-intelligence communications computers iot semiconductor tech-stocks
3 Communication Stocks Likely to Weather Industry Headwinds
by Supriyo Bose
The accelerated pace of 5G deployment and demand for scalable infrastructure should help the Zacks Diversified Communication Services industry thrive despite geopolitical headwinds. TEF, RCI and LUMN are well-positioned to make the most of the infrastructure upgrade for seamless connectivity.
TEFPositive Net Change RCIPositive Net Change LUMNNegative Net Change
communications iot mobile tech-stocks
Can IBM's Tie-Up With Cisco for Quantum Network Aid Its Shares?
by Supriyo Bose
IBM teams with Cisco to build a quantum network by 2030, aiming to drive breakthroughs in quantum computing and connectivity.
AMZNNegative Net Change AMDNegative Net Change MSFTNegative Net Change IBMNegative Net Change CSCONegative Net Change
cloud-computing computers iot software tech-stocks
Business First (BFST) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BFSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines